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Abstract
Background: CENP-E, one of spindle checkpoint proteins, plays a crucial role in the function of
spindle checkpoint. Once CENP-E expression was interrupted, the chromosomes can not separate
procedurally, and may result in aneuploidy which is a hallmark of most solid cancers, such as
hepatocellular carcinoma (HCC). We investigate the expression of CENP-E in human
hepatocellular carcinoma,. and analyze the effect of low CENP-E expression on chromosome
separation in normal liver cell line (LO2).
Methods: We determined its levels in HCC and para-cancerous tissues, human hepatocellular
carcinoma-derived cell line (HepG2) and LO2 cell line using real time quantitative PCR (QPCR) and
Western blot. Further to know whether reduction in CENP-E expression impairs chromosomes
separation in LO2 cells. we knocked down CENP-E using shRNA expressing vector and then count
the aneuploid in LO2 cells using chromosomal counts assay.
Results: We found that both CENP-E mRNA and protein levels were significantly reduced in HCC
tissues and HepG2 cells compared with para-cancerous tissues and LO2 cells, respectively. A
significantly-increased proportion of aneuploid in these down-knocked LO2 cells compared with
those treated with control shRNA vector.
Conclusions: Together with other results, these results reveal that CENP-E expression was
reduced in human HCC tissue, and low CENP-E expression result in aneuploidy in LO2 cells.
Background
Chromosomal or genetic instability (CIN) leading to an
aberrant chromosome number (aneuploidy) is a hallmark
of cancers[1]. A growing body of evidence suggests that
defects in the spindle checkpoint, a surveillance mecha-
nism crucial for the proper segregation of chromosomes
during every cell division, might promote aneuploidy and
tumorigenesis [2]. The spindle checkpoint machinery
consists of several proteins that are well-conserved in var-
ious species. These checkpoint proteins are recruited and
activated at the kinetochores of unattached and/or una-
ligned chromosomes, and subsequently inhibit the ana-
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prevent the ubiquitination of substrates whose destruc-
tion is required for advance to anaphase [3]. To date, two
checkpoint proteins are known for directly mediating the
activation or/and inactivation of spindle checkpoint, i.e.,
CENP-E and BubR1 [4-6].
CENP-E is a kinesin-like motor protein localized on the
kinetochore. It has an apparent molecular mass of 312
kDa, with an ATP-dependent motor domain located at the
N-terminus. CENP-E is required for efficient capture and
attachment of spindle microtubules by kinetochores, a
necessary step in chromosome alignment during promet-
aphase [7-10]. Disrupting the function of CENP-E by var-
ious methods consistently results in the appearance of
some unaligned chromosomes at metaphase. Previous
studies using either microinjection or the antisense
approach showed that cells with CENP-E defects had pro-
longed mitotic arrest, and even initiated apoptosis
[11,12].
Hepatocellular carcinoma (HCC) is one of the most com-
mon carcinoma causing death world widely. However,
genetic events in hepatic carcinogenesis are poorly under-
stood. It has been reported that CIN can be observed in
hepatoma carcinoma cell, resulting from defects of spin-
dle checkpoint genes. Sze KM et al have shown that all 6
hepatoma cell lines with defective mitotic checkpoint
showed significant reduced expression of mitotic arrest
deficient 2 (Mad2)[13]. Mad1beta, a novel splicing variant
of mitotic arrest deficient 1 (Mad1), was expressed at both
mRNA and protein levels in the nine hepatoma cell lines
tested and was over-expressed in 12 of 50 (24%) human
HCC tissues[14]. Jeong SJ et al have shown that transcrip-
tional dysfunction of hsMad2 is frequently observed in
hepatocellular carcinoma cells [15]. Marchio et al used
Comparative Genomic Hybridization (CGH) to evaluate
and map genomic aberrations in 50 hepatocellular carci-
nomas from patients chronically infected with hepatitis B
virus (HBV), and found nonrandom genomic imbalances
and spindle checkpoint genes alterations [16]. Thus, the
present study is designed to investigate the alteration of
CENP-E gene expression in human hepatocarcinoma tis-
sues, and study the fate of LO2 cells (normal liver cell
line) treated with CENP-E shRNA vectors, with a intend to




Twenty-one HCC tissue samples and eighteen para-can-
cerous tissue samples were obtained from the Department
of Surgery of the Liver & Biliary, the first and second affil-
iated hospitals of Chongqing Medical University, all of
which were confirmed by pathobiology. Informed con-
sents were obtained from all patients, and the medical
ethical committee of Chongqing Medical University
approved this study.
Cell culture and transfection
LO2 and HepG2 cells were cultured in Eagle's Minimum
Essential Medium media containing 100 mL/L fetal
bovine serum. Transfections were carried out with shRNA
vector and Lipofectamine 2000 transfection reagent (Inv-
itrogen) mixture. These components were mixed in
DMEM (serum free) according to the manufacturer's
instructions. For mock transfections, cells were treated
with Lipofectamine 2000 alone.
Design of target sequence of shRNA
Specific oligonucleotide sequences used to knock out
human CENP-E (NM_003870) were as follows: 1) 5'-
CGCAGTCGTTCTCATACCAT-3', 2) 5'-CCACG GATGCT-
GGTGACCTC-3', 3) 5'-CGCACGGATGCTGGTGACCTC-
3'. By BLAST analysis, these sequences have no homology
with other coding sequences in human. Scrambled
sequence used as negative control: 5'-CGAGTAAGACCAT-
TCA GGTC-3'. The 5'end of this sequence corresponds to
the cut-off point for BamHI enzyme (GATCC), while the
3'end, containing the T6 sequence, corresponds to the cut-
ting site for Hind III enzyme (AGCTT). A ring sequence of
9 base pairs exists between the sense and anti-sense
strands (TTCAAGAGA).
Construction of shRNA expression plasmid
Two strands of oligonucleotides would undergo anneal-
ing, ligation, and transformation. To identify positive
clones, the constructed shRNA expression plasmids were
identified by sequencing in Takara Biotechnology Com-
pany. shRNA vectors were named pGenesil-CENPE 1, 2, 3
and pScramble (negative control) respectively.
Real-time PCR analysis
Total RNA were isolated from adherent cells and clinical
samples using the TRIZOL reagent (Invitrogen). First-
strand cDNA was synthesized from 0.5 μg of total RNA by
using random hexamers. The primers used for quantitat-
ing CENP-E mRNA were 5'-GCGATGGAAGAACAACTAG-
GTACC-3 '(forward) and 5'-GTTG
CTTGGGACTGTAAAAGCTGT-3 ' (reverse) with a Taq-
Man-MGB(genecore, china) probe 5'(FAM)-AAAACGAG-
CACAGCGAAGAATAGCCAGAA-3'. Because CENP-E
degradation kinetically follows the proteolysis of Cyclin
B1 in anaphase, Cyclin B1 mRNA was used to normalize
CENP-E mRNA, for which the primers and TaqMan-MGB
probe were 5'-AGCACCTGGCTAAGAATG-3'(forward), 5'-
CTTCGATGTGGCATACTTG-3'(reverse), and 5'(FAM) -
ATCAAGGACTTACA AAGCACATG ACTGTC-3'. The PCR
cycling program was 94°C for 5 minutes, then 40 cycles of
94°C for 30 seconds, 51°C for 30 seconds.Page 2 of 8
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For CENP-E protein level analysis, cells and tissues were
lysed with RIPA lysis Buffer, supplemented with protease
inhibitors. The lysates were cleared by centrifugation at
14,000 rpm for 30 min at 4°C and quantitated by Brad-
ford Protein Assay. Protein was enriched by immunopre-
cipitation method, and the precipitates were boiled with
SDS-loading buffer, separated on 40-120 g/L and 100 g/L
SDS-PAGE respectively, and then transferred onto polyvi-
nylidene difluoride membrane (Millipore). Thereafter,
the membrane was probed with affinity-purified mouse
monoclonal antibody against human CENP-E (Abcam,
USA) and mouse monoclonal antibody of Cyclin
B1(Abcam, USA), followed by horseradish peroxidase-
conjugated secondary antibody. After washing, the mem-
brane was incubated in ECL Plus reagent before detection.
Then, the blots were scanned in grey scale and analyzed
using QUANTITY ONE software.
Immunofluorescence Microscopy
LO2 cells were seeded onto sterile, acid-treated 12-mm
coverslips in 24-well plates. Nocodazole-treated LO2 cells
were applied to poly-L-lysine-coated coverslips. The cov-
erslips were rinsed in PBS, and the cells were fixed by 4%
paraformaldehyde for 10 min plus 2 ml/L Triton X-100
for 10 min at room temperature. The cells were then incu-
bated at 37°C sequentially with: (a) mouse anti-CENP-E
monoclonal antibody (1:250;Abcam), (b) Rhodamine-
conjugated goat anti-mouse IgG (1:20, KPL), and (c) 0.1
μg/ml 4',6'-diamidino-2-phenyl-indole (DAPI). Cells
were rinsed extensively in PBS between each incubation,
and all reagents were diluted in PBS/5% bovine serum
albumin. Finally, the coverslips were mounted and
viewed in a confocal microscopy (SP5, Lecia). All images
in each experiment were collected on the same day using
identical exposure times.
MTT assay
For measurements of cell proliferation rates, cells were
planted into 96-well plates at a density of 1 × 103/100 μl.
Then, the plates were incubated for 1, 2, 3, 4, 5, 6 or 7
days, added into MTT solution (10 μl/well), incubated for
4 h at 37°C, and measured the absorbance of 450 nm UV
in a microplate reader. Each assay was done in triplicate
wells, and each experiment was repeated three times.
Measurement of apoptosis
After 24 hours of transfection, digested the cells of each
group by Trypsin, suspended them in PBS, and centri-
fuged them for 10 min at 1000 rpm. Then, discarded the
supernatant, resuspended the pellet cells in 500 μl of 1×
Binding Buffer into which added 5 μl annexin V-PE stain-
ing solution, and incubated them at room temperature for
5 min in the dark.
Chromosome counts
After treated with nocodazol (Sigma-Adrich) for 3 hours,
the cells were incubated 6 hours,, centrifuged 5 minutes at
2500 rpm, and resuspended in 5 ml hypotonic solution
(0.05 M KC1: 0.25% trypsin EDTA, 3:1) and maintained
at 37°C for 20 minutes. Then 1 ml fixative (methanol:ace-
tic acid, 3:1) was added into the tube, and the suspension
was centrifuged immediately. The pellet was resuspended
in 5 ml of methanol for 5 min, and then the cells were
centrifuged and resuspended in 5 ml fixative. This step
was repeated twice. After centrifugation, the cell pellet was
dropped onto chilled wet slides and immediately put
under a hot air flow to evaporate the fixative rapidly.
Statistical analysis
The SPSS 13.0 software was used to establish database for
statistical analysis. The data were represented in form of 
± s. Single-factor variance analysis and Independent-Sam-
ples T Test were used, where p value less than 0.05 was
considered as statistical significance.
Results
Reduced expression of CENP-E in HCC tissues and HepG2 
cells
Real-time quantitative PCR (QPCR) and western blot
analysis were used to characterize the expression of CENP-
E in HCC and para-cancerous tissues, and HepG2 and LO2
cells. The level of CENP-E was normalized by Cyclin B1.
Results showed that the mRNA level of para-cancerous tis-
sue (0.826 ± 0.014) was significantly higher than that of
HCC tissue (0.321 ± 0.023)(t = 12.1, P = 0<0.0). To con-
firm the results from clinical tissues, we investigate the
level of CENP-E mRNA in HepG2 and LO2 cells. After
treating them with nocodazole, we collected the mitosis
cells for detection, and found that the level of CENP-E
mRNA in LO2 cells (0.814 ± 0.019) was significantly
higher than that of HepG2 cells (0.239 ± 0.019)(t = 17.9,
P = 0<0.05)(fig. 1B).
The results of western blotting were consistent with those
of QPCR, CENP-E protein level in HCC tissues (0.267 ±
0.038), as measured by western blot, were diminished by
about one-fold as compared with that of the para-cancer-
ous tissues (0.762 ± 0.041)(t = 12.2, P = 0<0.05), and only
about half of CENP-E in HepG2 cells (0.257 ± 0.039)
extract could be detected as compared in LO2 cell extract
(0.759 ± 0.023) (fig. 1A) (t = 13.2, P = 0<0.05).
Transfection with CENP-E shRNA efficiently knocked 
down CENP-E in the LO2 Cells
shRNA vector targeting for CENP-E and control shRNA
vector were delivered into LO2 cells, and their knockdown
efficiencies in LO2 cells were compared. QPCR analysis
consistently showed an 75~80% reduction of CENP-E
xPage 3 of 8
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was used for the remaining of this study (Fig. 2B). Next,
we examined the knockdown of CENP-E at the protein
level by Western blotting. We compared the level of
CENP-E protein in extract of cells 24 h after transfection
with pGenesil-CENPE3 with those untransfected cells and
transfected with pScramble. Only a small amount of
CENP-E was detected in 75 mg of lysates of pGenesil-
CENPE3 transfected cells. CENP-E protein levels, as meas-
ured by quantitative immunoblotting, were diminished
by at least 7-8 fold as compared with those untransfected
cells and pScramble transfected cells (Fig. 2A, top). Mean-
while, we detected the amount of CENP-E protein at sin-
gle cell level by indirect immunofluorescence assay. In
pScramble-transfected cells, the signals corresponding to
CENP-E were readily detected in mitotic cells (Fig. 2C,
top); however, in CENP-E shRNA-transfected cells, signal
was undetectable. Therefore, the shRNA vector can effi-
ciently knockdown the CENP-E in LO2 cells.
Deletion of CENP-E induced apoptosis and slowed down 
proliferation in LO2 cells
Cell proliferation activity was examined using MTT assay.
The proliferation rate of pGenesil-CENPE3-transfected
cells was lower than that of pScramble-transfected and
untransfected LO2 cells (fig. 3A). The percentage of apop-
tosis [(16.57 ± 1.4)%] in pGenesil -CENPE3 mediated
cells was significantly higher than that in cells transfected
with pScramble [(2.84 ± 0.84)%] (t = 29, P = 0<0.05) and
mock vectors [(2.61 ± 0.4)%] (t = 33, P = 0<0.05). Apop-
tosis in cells transfected with pGenesil-CENPE3 was pre-
sented in fig. 3B.
Depletion of CENP-E caused aneuploidy in LO2 cells
To investigate whether depletion of CENP-E in LO2 cells
affected the separation of chromosome and cause aneu-
ploid cells, cells transfected with pGenesil-CENPE3 and
pScramble were analyzed by chromosome account 24 h
later (fig. 4A). Results demonstrated that aneuploid
increased significantly in pGenesil-CENPE3-treated LO2
cells [(25.1 ± 2.8)%], compared with those in pScramble-
treated [(5.57 ± 1.8)%] (t = 44.2, P = 0<0.05) and untras-
fected cells [(4.69 ± 1.3)%] (t = 50.9, P = 0<0.05) (fig. 4B).
Discussion
The centromere proteins are crucial for centromere assem-
bly and centromere function. CENPs dysregulation have
been reported in some cancers tissues or cell lines. Centro-
mere protein-A overexpress in human primary colorectal
cancer and HCC [17,18]. Obrien et al [19] found that the
expression of centromere protein CENP-F was associated
with the prognosis of early breast cancer. CENP-H expres-
sion was higher in tongue cancer cell lines and nasopha-
ryngeal carcinoma cell lines [20,21]Therefore, to study
centromere proteins may contributes to exploring the
mechanism of chromosome segregation, revealing the
mechanism of malignant cellular proliferation and find-
ing cancer marker proteins, and also may provide new tar-
gets for carcinoma therapy and prognosis estimation of
cancer patients.
Reduced expression of CENP-E in human hepatocellular 
carcinoma
CENP-E is also one of the components directly responsi-
ble for capturing and stabilizing spindle microtubules by
kinetochores [9,10]. CENP-E interacts with BubR1 and
stimulates its kinase activity, which implicates its role in
activating and maintaining mitotic checkpoint signalling
[6,19]. Deletion CENP-E by various methods could
impair the function of spindle checkpoint [9,12]. In this
study we found that the mRNA and protein expression
levels of CENP-E were reduced both in HCC tissues and in
human hepatocellular carcinoma-derived cell lines
(HepG2), and that the LO2 cells transfected with shRNA
vector had a decreased proliferation rate and an increased
proportion of aneuploid and apoptosis cells.
Reduced expression of CENP-E may be involved in human 
hepatocarcinogenesis
Our evidence presents that the level of CENP-E protein
was reduced in the HCC tissues, which implicates that
CENP-E may be involved in human hepatocarcinogene-
sis. We draw this conclusion from two aspects as follows:
(1) Aneuploidy is related with tumorigenesis. A majority
of human cancer cells are aneuploid due to an underlying
chromosomal instability phenotype [22]. Theodor Boveri
proposed an aneuploid hypothesis, in which, aneuploid
was presumed as a direct cause of cancerous transforma-
shows that CENP-E expression in HCC and para-cancerous tissues, LO2 and HepG2 cell li esFig re 1
shows that CENP-E expression in HCC and para-can-
cerous tissues, LO2 and HepG2 cell lines. (a) Analysis 
of CENP-E protein levels by Western blot. lysis extracts 
derived from para-cancerous tissues (lane 5-6), HCC tissues 
(lane1-4), LO2 (lane 7) and HepG2 cell lines (lane 8), Cyclin 
B1 was simultaneously immunoprobed for loading control. 
(b) QPCR and western blot analysis for CENP-E of tissues 
and cell lines, Cyclin B1 serves as loading control. Data rep-
resent the mean ± S.E. of three independent experiments. #, 
P < 0.05 versus HCC tissues; *, P < 0.05 versus HepG2 cellsPage 4 of 8
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suppressors in the late 1970s and 1980s, some researchers
suggested that heterozygosity loss might result in the phe-
notypic expression of mutated tumour suppressor genes
in the aneuploid cell, and aneuploid cells may show chro-
mosome polysomy that harbours oncogenes [24]. Aneu-
ploid is still an important cause of tumorigenesis, and
oncogenes hypothesis also supports this point, although
there is no direct evidence to confirm that aneuploidy is a
primary contributor to tumorigenesis up to now.
(2) Cancer is associated with weakened spindle check-
point. A growing body of evidence suggests that defects in
the spindle checkpoint might promote aneuploidy and
tumorigenesis. Mouse with reduced expression of spindle
checkpoint proteins survived but developed aneuploidy at
an elevated rate, and in some, but not all cases, these ani-
mals are more susceptible to spontaneous tumours
[25,26] Cells over-expressing Mad2 developed a large
number of chromosome breaks, fragments, and fusions in
addition to whole chromosomal aneuploidy [27]. Muta-
tion of mitotic checkpoint genes such as BubR1, Mad2,
has been found in colon cancer lines, and breast cancer,
respectively [28,29]. Mosaic variegated aneuploidy
(MVA), which is characterized by an increase in aneu-
ploidy (>25% of cells exhibit near-diploid aneuploidy)
and childhood cancers [30]. Five of eight MVA patients
were found to have mutations in both alleles of BubR1
gene. Aneuploidy occurred in the pGenesil-CENPE
shRNA-treated LO2 cells in this study, for which one
potential explain is that the level of CENP-E may affect
spindle checkpoint. Once the level of CENP-E protein was
decreased, the onset of unaligned chromosomes and ane-
uploidy was induced in the anaphase. Completely inacti-
vating the checkpoint would result in cell autonomous
lethality because of large loss or gain of chromosome;
however, cells with a weakened checkpoint could survive
but exhibit chromosomal instability. In our study, the
level of CENP-E protein was down-regulated dramatically,
thus the spindle checkpoint of LO2 cells treated with
shRNA vector might be subjected to a large degree of dam-
age, some of which even suffer apoptosis or death. These
points are also proved by our MTT result and are consist-
ent with those of Marcel Tanudji [31].
Analysis interferer efficiency of pGenesil-CENPEFigure 2
Analysis interferer efficiency of pGenesil-CENPE. (A)Analysis of CENP-E protein levels by Western blot. Seventy-five 
micrograms of mitotic extracts derived from LO2 cells treated by nocodazol before detection for 3 h (lane 1-5). (B)shRNA-
induced reduction of CENP-E mRNA and protein levels. Reduction of CENP-E mRNA. LO2 cells were transfected with vari-
ous CENP-E shRNA vectors as indicated, and the mRNA levels were measured 24 h posttransfection by QPCR. Control:nega-
tive control (pScramble); mock: transfected Lipofectamine 2000 only alone. (C)Immunofluorescence of CENP-E of LO2 cells 
24 h posttransfection with control shRNA vector or CENP-E siRNA. Cells were double stained with DAPI (4,6-diamidino-2-
phenylindole) and CENP-E antibodies. Identical exposure times were used for imaging both control and CENP-E shRNA-trans-
fected cells (white arrow point to misaligned chromosome). Bar, 5 μm.Page 5 of 8
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hepatocarcinogenesis
Beth A.A. Weaver has demonstrated that aneuploidy
resulted from CENP-E+/-, which acts as an oncogene as
well as a tumour suppressor. Widespread aneuploidy was
accompanied by a 50% decrease of spontaneous liver
tumours in aged CENP-E+/- mice compare with CENP-E+/+
mice [32]. In the present study, we found that CENP-E
decreased by about 50% in HCC tissue as compared with
that in para-cancerous tissue. Possible explanations for
these contradictions may be:
(1) Firstly, We tentatively put forward that the threshold
level of CENP-E protein for promoting tumorigenesis
might be in the range of 20-50% of the normal. The rate
of apoptosis or death increased obviously in LO2 cells,
when CENP-E was down-regulated to 15-20% in this
study. However, aneuploidy due to reduced CENP-E
(about 50% of the normal level) in CENP-E+/- mouse
could act as a tumour suppressor. CENP-E in HCC tissue
may be lower than the threshold value and higher than
15-20% of the normal level, and then may be promoting
hepatocarcinogenesis.
(2) Secondly, the control samples used in our study may
affect our final results. Because the expression level of
CENP-E protein in para-cancerous may be lower than that
of the normal liver tissue which was unavailable in the
present study, the level of CENP-E in HCC tissue may be
no higher than 50% of the normal.
(3) Finally, our results supported the following hypothe-
sis, as proposed previously by Salmon's and Yen's labora-
tories [33]. A certain level of the waiting-anaphase signal
may be required for cells to induce mitotic arrest. When
CENP-E is reduced lightly in cells, the accumulation of the
signals generated at each kinetochore is still sufficient to
reach the threshold required for mitotic arrest, and ana-
phase onset accompanied unaligned chromosomes pro-
moting aneuploidy. When CENP-E is reduced to a larger
extent, the accumulation of the signals may not be suffi-
cient to arrest mitosis, and cells possessing mitosis with
large loss or gain of chromosome may suffer apoptosis or
death.
Despite the fact that reduced expression of CENP-E pro-
tein was found in HCC tissues and could induced apopto-
sis and aneuploidy in LO2 cells, our results do not provide
proliferation and apoptosis analysis by MTT assay and flow cytomertyFigure 3
proliferation and apoptosis analysis by MTT assay and flow cytomerty. (A) shows that proliferation of LO2 cells 
expression shRNA. Proliferation of shRNA-transfected LO2 cells (clone 3), shRNA scramble control and un-transfected LO2 
cells were analyzed by MTT assay as described earlier. The mean ± SE of three independent experiments are shown. LO2 cells 
transfeced with pGenesil-CENPE vector proliferation slowed. (B) the result of flow cytometry showed that the percent of 
apoptosis cells of LO2 cells transfected with pGenesil-CENPE vector is higher than cells transfected with scrambler control 
shRNA vector or mock.Page 6 of 8
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initiate hepatocarcinogenesis. However, this problem
might be solved if we down-regulate the level of CENP-E
to various degrees by constructing interfere vector or find-
ing microRNA to target CENP-E, and investigate the rela-
tionship between the reduced CENP-E expression and
hepatocarcinogenesis.
In a word, we found that CENP-E expression was reduced
in HCC tissue, and reduced CENP-E expression could
interfere with the separation of chromosome in LO2 cells.
Conclusions
Together with other results, these results reveal that
CENP-E expression was reduced in human HCC tissue,
and low CENP-E expression result in aneuploidy in LO2
cells.
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